Biomarkers Atlas的动态

Discover the Power of Systems-Based Medicine with Mosaic Biodata In the evolving landscape of healthcare, traditional approaches are giving way to more holistic, integrated methodologies. Enter systems-based medicine—a revolutionary approach that considers the complex interplay of genetics, environment, lifestyle, and more to deliver personalized healthcare solutions. What is Systems-Based Medicine? Systems-based medicine goes beyond treating symptoms. It involves understanding the root causes of health issues by analyzing various biological systems and their interactions. This comprehensive approach helps in predicting, preventing, and treating diseases more effectively. Why Mosaic Biodata? At Mosaic Biodata, we leverage cutting-edge technologies and deep scientific insights to provide you with a detailed understanding of your health. Our personalized reports offer actionable insights, helping you and your healthcare provider make informed decisions. Join us in embracing the future of healthcare. Discover how systems-based medicine can transform your health journey with Mosaic Biodata. #HealthcareRevolution #SystemsBasedMedicine #PersonalizedMedicine #MosaicBiodata #InnovativeHealth #Genomics #HolisticHealth Daniel Stickler, M.D.

As three of my favorite humans working in this space - Diane Stephenson, Sarah A., and Yuge Xiao - state so clearly in this brilliant new Pharmaceutical Executive piece, "Digital health technologies offer exciting new opportunities to accelerate research, enhance clinical care, and ultimately improve outcomes for those living with Parkinson's Disease." Our ability to harness the potential of digital health technologies for Parkinson's disease hinges on our collective commitment to collaboration and open science. These principles are not just buzzwords, but the key to developing tools that are equitable, ethical, and trusted by all stakeholders-patients, clinicians, regulators, and payers. I'm incredibly proud of the collaboration between Critical Path Institute (C-Path), The Michael J. Fox Foundation for Parkinson's Research, and the Digital Medicine Society (DiMe), which created the catalog of evidence-based digital health products for Parkinson's disease within our Library of Digital Measurement Products. Check out the library here ?? https://lnkd.in/eb2h2FC5 and join us in maintaining this resource for the field by submitting new tools as our community releases them. And if you're looking for a bit of inspiration this morning, check out Diane, Sarah, and Yuge's piece here ???https://lnkd.in/eESRDFxw

?? Today is the day! ?? It’s time for our life sciences online conference. ?? We’ll be talking about everything from clinical trials and genomics to patient safety and digital technology! First up, we have a keynote from Robert Salter, consultant innovation scientist at Cwm Taf Morgannwg University Health Board ?? ?? Follow the link below to watch live ?????? https://lnkd.in/eHWc_fJM ?? Follow this thread for live updates. #LifeSciences

This week, we interview William Hind, CEO of Alpharmaxim Healthcare Communications, on their innovative Healthcare Behaviour Insights Tool (H-BIT) developed with Aston University. ???? Discover how H-BIT uses behavioral science to address barriers in adopting new medical therapies and its potential impact on the pharma sector. Get insights into the inspiration behind the tool, overcoming challenges, and tips for aspiring leaders. https://lnkd.in/dUEBw4kF

?????????????????? ???????????????? ???? ???????????????????? ?????? ???????????? ???? ????????????????????, ?????? ?????? ???????? ?????????????????? ?????????????? ????????????????. While we've made significant strides in understanding the genetic underpinnings of diseases and developing targeted therapies, translating these discoveries into routine clinical practice presents substantial challenges. Data integration, interdisciplinary collaboration, and ethical considerations are just a few of the hurdles we must overcome. Additionally, ensuring equitable access to precision medicine for all patients is paramount. By fostering innovation, investing in research, and addressing these challenges head-on, we can accelerate the realization of personalized healthcare. I'm eager to connect with professionals who share my passion for precision medicine. Let's discuss how we can collaborate to shape the future of healthcare together. #precisionmedicine #healthcare #medicine #clinicalpractice #biomedicalresearch #innovation #healthcareaccess

Moments like #MyelomaActionMonth remind us that while there have been recent scientific advances, patients still face delays to access the treatments they urgently need. We must continue to work together to find new solutions to address this unmet need.? ? I am excited to share my recent article in @ThePharmaLetter focusing on the importance of real-world evidence in supporting patient access to innovation.? ? You can read the article here – let me know your thoughts in the comments: https://lnkd.in/dcmG7w_W

?? Webinar Announcement: Improving Outcomes and Access to Precision Medicine??- https://lnkd.in/eSvkPZPG Despite groundbreaking advances in precision medicine, a critical gap remains: the lack of diverse representation in genomic data, leading to unequal healthcare outcomes—especially for people of color. ?? What is the impact? Genomic testing is a cornerstone of modern medicine, yet current databases are largely based on data from individuals of European descent. This leaves underrepresented populations at a disadvantage, with less effective treatments and limited access to life-saving innovations. ??What you’ll learn: 1?? Understanding the genomic testing gap and the structural barriers in healthcare 2?? How to advance precision medicine for all, ensuring inclusivity 3?? Practical strategies for improving access, including policy changes, community engagement, and innovative healthcare models ?? Date: Thursday, 21st November, 2024 ? Time: 12:00pm - 1:00pm ET ?? Location: Zoom (Register Here https://lnkd.in/eSvkPZPG) Let’s work together to create a healthcare system that serves everyone. #PrecisionMedicine #GenomicTesting #HealthEquity

Momentum is growing around behavioural science. It gives life science leaders the opportunity to pinpoint exactly what patients want from new drugs and therapies, and can promote the latest breakthroughs to stakeholders across the healthcare ecosystem. To learn more, read this guest column from earlier this year by William Hind (Alpharmaxim) and Lisa Campbell (SSI Strategy) in Life Science Leader: https://lnkd.in/eaPJCMWp

There is so much potential for expanding #researchimpact in consortium projects. Just finished a structured dialogue, a process of collective thinking that is much more effective than #brainstorming, with the P4O2 - Precision Medicine for more Oxygen consortium which is a public/private partnership funded by Health~Holland They have completed a study with a #longcovid cohort and now the opportunity is to do follow on analysis beyond the initial set of papers. I clustered the existing papers, papers in development and ideas around papers using a number of different themes. I then added the initial results of analysis as well as an overview of the data available. The consortium was then asked to add ideas that connected or related to the different papers and concepts. The result? Ten ideas for analyses/papers in 5 minutes. That is two a minute! We are of course going to continue this effort, but it shows the potential of #collectiveintelligence to widen the impact of research. Anke-Hilse Maitland-van der Zee Yolanda de Wit-van Wijck Twan Kerssens

Our first paper announced for the 2024 Basel Chapter meeting, is entitled... ‘The Patient Life Experience (PLE) Approach: Using social science methodology to examine diverse patient lives and reduce health’. Our speakers for this paper are –?Beyza Klein, Novartis and Rebekah Park, Gemic Take a look at the details of the Basel chapter meeting here on the EPHMRA website – https://lnkd.in/dJgGeqam #ephmra?#businessintelligence